Abstracts

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29 Wed, Sep 30

Monday, September 28

3:25 PM - 3:30 PM ET

1064 - Assessment of Image Guidance and Adaptive Planning on the ART of SABR Phase II Trial for Near "Margin-Less" Adaptive Radiation Therapy of Primary Localized Prostate Cancer
Speaker: Morris, Toby - Mayo Clinic, Scottsdale, AZ
3:25 PM - 3:30 PM ET

1076 - Spatiotemporal AI Morphometry Predicts Early Recurrence in Rectal Cancer Post-nCRT: A Multi-Model Ablation Study
Speaker: Chen, Shenlun, PhD - Fudan University Shanghai Cancer Center, Shanghai, Shanghai
3:30 PM - 3:35 PM ET

1047 - Predicting Survival and Treatment Completion of Proton Craniospinal Irradiation in Leptomeningeal Disease: A Prognostic Nomogram
Speaker: Kanala, Tejaswi, MD, MBBS - MD Anderson Cancer Center, Houston, TX
3:30 PM - 3:35 PM ET

1053 - Phase II Study of Stereotactic Body Radiation Therapy with Simultaneous Integrated Boost (SBRT-SIB) Delivered on an MR-LINAC for Intermediate and High Risk Prostate Cancer: 2 Year Outcomes
Speaker: Weg, Emily, MD - Weill Cornell Medicine, New York, NY
3:30 PM - 3:35 PM ET

1059 - Proton Beam Therapy vs. IMRT for Nasopharyngeal Carcinoma: Differential Late Toxicity Profile at 5 Years
Speaker: Taghizadeh Mortezaei, Nima, MD - Mass General Brigham, Harvard Medical School, Boston, MA
3:30 PM - 3:35 PM ET

1065 - Universal Zero-Shot Contour Propagation via Prior-Guided Learning for Adaptive Radiotherapy
Speaker: Lyu, Zeyang - Fudan University Shanghai Cancer Center, Shanghai, DC
3:30 PM - 3:35 PM ET

1077 - Dynamic Delta-Radiomics and Clinical Fusion Model for Predicting Disease-Free Survival In Locally Advanced Cervical Cancer: A Multi-Cohort Study
Speaker: Wang, Weiping, MD, PhD - Peking Union Medical College Hospital, Beijing, Beijing
3:30 PM - 3:40 PM ET

213 - Circulating Tumor DNA (ctDNA) as an Early Predictive Biomarker of Response In Locally Advanced Cervical Cancer Treated with the Interlace Regimen: A Preliminary Report
Speaker: Gui, Bin, MD, MS - Northwell Health, Lake Success, NY
3:30 PM - 3:40 PM ET

218 - CDCP1-Directed <sup>89</sup>Zr/<sup>177</sup>Lu Radiotheranostics for Radioresistant Non-Small Cell Lung Cancer
Speaker: Liu, Jie, PhD - Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan
3:30 PM - 3:40 PM ET

224 - Event-Free Survival after Definitive Radiotherapy vs. Upfront Surgery for Axillary and Inguinal Nodal Merkel Cell Carcinoma: A Population-Based Retrospective Analysis
Speaker: Stoker, Daniel, MD - Queensland Health, Douglas, QLD
3:35 PM - 3:55 PM ET

Questions & Answers
Speaker: Yang, Jonathan, MD, PhD - New York University School of Medicine, New York, NY
3:35 PM - 3:55 PM ET

Questions & Answers
Speaker: Shen, Colette, MD, PhD - University of North Carolina School of Medicine & Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina